Innitius reduced Business Plan

1. INNITIUS WWW.INNITIUS.COM

2. PREEMIE?
15.000.000
E v e r y y e a r
P R E M A T U R E D E L I V E R I E S ( 1 0 % O F T H E T O T A L )
L E A D I N G
I N F A N T
M O R T A L I T Y
C A U S E
$26.2 B / YEAR
Economic burden Associated in usa:
80%
20%
70%
30%
2 0 % 3 0 %
M E M B R A N E S
R U P T U R E
I N F E C T I O N S
50%50%
preterm deliveries sources:
T H R E A T E N E D P R E T E R M
L A B O R ( T P L )
5 0 %

3. PHYSICIANS WITH THE
BACK AGAINST THE
WALL
8 5 %T P L P A T I E N T S D O N ' T
D E L I V E R W I T H I N T H E
N E X T 7 D A Y S
$8.000
A n a v e r a g e o f
I S T H E A S S O C I A T E D C O S T F O R
E A C H U N N C E S S A R Y
H O S P I T A L I Z A T I O N
Cervicometry:
H I G H F A L S E
P O S I T I V E C A S E S
R A T I O
I N - V I T R O
D I A G N O S T I C S
THREATENED PRETERM LABOR:
Safety
First
PROBLEM

4. real
time
low
cost
improving
cervicometry
reliability
BEING INCLUDED AT
CLINICAL
PROTOCOLS
TO REDUCE THE NUMBER
OF UNNECESSARY
HOSPITALIZATIONS
A I M : S T R A T E G Y :
SOLUTION
W E P R O P O S E A S O L U T I O N . . .

5. &
T O R S I O N A L
W A V E S
A R T I F I C I A L
I N T E L L I G E N C E
OWN
TECHNOLOGY
P E R T E S T
P E R F O R M E D
3 €
E S T I M A T E D
C O S T
S C I E N T I F I C B A S E : T O M E A S U R E
T H E C E R V I C A L C O N S I S T E N C Y
TECHNOLOGY COVERED BY 2 PATENTS AT NATIONAL PHASES
every TPL
I T W O U L D A L L O W T O B E
A P P L I E D A T
PRODUCT

6. Add-on to every new & current
ultrasound system
BUSINESS MODEL
Income
Source #1
25%
Income
Source #2
5%O V E R L I C E N S E E
P R O F I T S I N C R E A S I N G
B E F O R E T A X E S -
A F T E R T H E
I M P L E M E N T A T I O N O F
T H E F I N E B I R T H I N T O
I T S P I P E L I N E -
O V E R L I C E N S E E N E T
S A L E S O F F I N E B I R T H
F O R B E I N G A D D E D
I N T O C U R R E N T
U L T R A S O U N D
S Y S T E M S
add-on
+
€5.000
E S T I M A T E D P R I C E
P E R U N I T
cervical cancer prostate cancer
FOLLOWING APPLICATIONS

7. Market: Ultrasound-systems are
present at every GYN/OBS office
MARKET
LAST MOVER
ADVANTAGE
mature market with a new technology
IVD
CURRENTLY
MARKET;
KEY
PLAYERS: ultrasound
systems
OPENING A NEW
MARKET FOR
M A R K E T S I Z E
€ 1 . 0 7 2 M
/ Y E A R
M A R K E T S I Z E
> 2 8 . 0 0 0
U / Y E A R
ULTRASOUND-SYSTEMS MARKET:
T H E B I G T H R E E

8. COMPETITORS & COMPETITIVE ADVANTAGE
HIGH PREDICTING VALUE
LOW PREDICTING VALUE
EXPENSIVE CHEAP
IVDCompetitors
No
One
Cervicometry
Competitors
Fine Birth
MAIN CHARACTERISTICS &
COMPETITIVE ADVANTAGES:
E A S Y T O U S E
L O W C O S T : 3 €
/ T E S T
S P E C U L U M I S
N E E D E D
R E A L T I M E
D I A G N O S T I C
I N T E G R A T E D I N T H E
U L T R A S O U N D
S Y S T E M S
I M P R O V I N G
C E R V I C O M E T R Y
R E L I A B I L I T Y
Competition

9. CURRENT STATE
tech validate
at lab & real
environmet
84 PREGNANT
WOMEN
FEB 2019
SEP 2019
Device safety's
certification &
Prototypes
manufacturing
OCT 2019
MAR 2020
Clinical trials450 PATIENTS : UK,
ESPAÑA & POLONIA
CE mark
MAR 2020
DIC 2020
JAN 2021
DEVELOPMENT PLAN
Now
1
2
3
Goal

10. R U B É N M O L I N A ,
C E O
MsC Biomechanics
Participant: 100 Paths to Success
(IE Cajasol), CaixaImpulse 2016
(Caixa Capital Risc), Xplorer
(Santander Banc), Emprende
inHealth (Eli Lilly & UnLTD Spain)
Founders
G U I L L E R M O R U S ,
C T O
PhD. Numerical Methods
>50 published papers
>100 oral presentations at international congresses
11 published books
He has collaborated with UCL, Calltech, NASA, TU
Hamburg & Andong Korea.
F R A N C I S C A M O L I N A ,
C T O
PhD. In Obstetrics.
>50 published papers
>100 oral presentations at
international congresses
>10 times as IP at projects funded
Obs&Gine Spanish Asso. Vice.
Advisors
PhD in Obstetrics
>1000 published papers
He introduced the screening of
chromosomal and structural
abnormalities, has improved the
screening and prevention of pre-
eclampsia and premature birth and
allowed the development of fetal
therapy)
P R O F . N I C O L A I D E S
C L I N I C A L A D V I S O R
C A R L O S Á L V A R E Z ,
B U S I N E S S D E V E L O P M E N T
MsC Market Research & Strategic
Marketing
Knowledge Investor’s Director
Knowledge Agents Alliance’s Marketing
Director
Colaborator & mentor with more than 100
startups. Also investor & Non-Ex. Director
of some of them
R A F A M U Ñ O Z ,
S T R A T E G I S T A D V I S O R
MBA (IE, Spain) & PhD. Industrial Engineering
>15 year at business initiatives
>5 companies launched
Associated Professor at University of Granada
Associated Professor at ESIC Business School.
TEAM

11. Working team
TEAM
2017
2018
2019
1 F T
3 F T
2 P T
7 F T
3 P T
Theteam
is
growing

13. C R O W D F U N D I N G
6 0 0 . 0 0 0
€
V E N T U R E C A P I T A L / P U B L I C
F U N D I N G
1 . 2 0 0 . 0 0 0
P R E - M O N E Y V A L U A T I O N
2 . 5 0 0 . 0 0 0
WE ARE LOOKING FOR 1, 8M €, DIVIDED AS FOLLOW:
€ €
x7
R O I
2022
EXIT
C R O W D F U N D I N G P L A T F O R N

14. HOW IT WORKS:

15. HOW IT WORKS:
A T P R E S E N T : J U S T A
L O I
Y O U C A N I N V E S T F R O M
5 0 0 €
W I T H U S , Y O U R
S H A R E S H A V E
V A L U E
G U A R A N T E E D

16. 7 9
%
8 3
%
8 4
%
8 0
%
TEAM SCIENCE INNOVATION
BUSINESS
POTENTIAL
OUTPUTS, PARTNERS & ALLIANCES

17. INNITIUS WWW.INNITIUS.COM